Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, anal… Read more
Evolent Health Inc (EVH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.019x
Based on the latest financial reports, Evolent Health Inc (EVH) has a cash flow conversion efficiency ratio of 0.019x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($15.81 Million) by net assets ($842.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Evolent Health Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Evolent Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Evolent Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evolent Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sichuan Qiaoyuan Gas Co.Ltd
SHE:301286
|
0.005x |
|
SYLVANIA PLAT. DL 001
F:31L
|
N/A |
|
PetroTal Corp
OTCQX:PTALF
|
0.086x |
|
Candel Therapeutics Inc
NASDAQ:CADL
|
-0.128x |
|
Singapore Land Group Limited
PINK:UILCF
|
0.011x |
|
Niu Technologies
NASDAQ:NIU
|
0.050x |
|
OCEANA GRP RC-001
F:O1F
|
N/A |
|
Shenzhen Bromake New Material Co. Ltd. A
SHE:301387
|
N/A |
Annual Cash Flow Conversion Efficiency for Evolent Health Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Evolent Health Inc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.00 Billion | $18.77 Million | 0.019x | -85.97% |
| 2023-12-31 | $1.07 Billion | $142.58 Million | 0.134x | +1093.40% |
| 2022-12-31 | $859.42 Million | $-11.55 Million | -0.013x | -124.06% |
| 2021-12-31 | $693.63 Million | $38.75 Million | 0.056x | +313.32% |
| 2020-12-31 | $619.60 Million | $-16.23 Million | -0.026x | +42.95% |
| 2019-12-31 | $929.05 Million | $-42.65 Million | -0.046x | -164.36% |
| 2018-12-31 | $1.19 Billion | $-20.65 Million | -0.017x | +35.02% |
| 2017-12-31 | $1.05 Billion | $-27.96 Million | -0.027x | +31.36% |
| 2016-12-31 | $912.11 Million | $-35.51 Million | -0.039x | -83.49% |
| 2015-12-31 | $934.58 Million | $-19.83 Million | -0.021x | -100.06% |
| 2014-12-31 | $-2.07 Million | $-75.09 Million | 36.277x | +8363.21% |
| 2013-12-31 | $31.04 Million | $-13.63 Million | -0.439x | +82.12% |
| 2012-12-31 | $5.20 Million | $-12.77 Million | -2.455x | -- |